A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
Public ClinicalTrials.gov record NCT02161718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This double-blind, randomized study will evaluate the efficacy, safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD).
Study identification
- NCT ID
- NCT02161718
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Actual)
- Primary completion
- Jan 11, 2017 (Actual)
- Completion
- Feb 1, 2017 (Actual)
- Last update posted
- Oct 8, 2021
2014 – 2017
United States locations
- U.S. sites
- 58
- U.S. states
- 20
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Little Rock | Arkansas | 72211 | — |
| Alkermes Investigational Site | Springdale | Arkansas | 72764 | — |
| Alkermes Investigational Site | Anaheim | California | 92805 | — |
| Alkermes Investigational Site | Culver City | California | 90230 | — |
| Alkermes Investigational Site | Garden Grove | California | 92845 | — |
| Alkermes Investigational Site | Irvine | California | 92617 | — |
| Alkermes Investigational Site | La Jolla | California | 92037 | — |
| Alkermes Investigational Site | Long Beach | California | 90822 | — |
| Alkermes Investigational Site | National City | California | 91950 | — |
| Alkermes Investigational Site | Oakland | California | 94612 | — |
| Alkermes Investigational Site | Oceanside | California | 92056 | — |
| Alkermes Investigational Site | Orange | California | 92868 | — |
| Alkermes Investigational Site | San Diego | California | 92123 | — |
| Alkermes Investigational Site | San Francisco | California | 94121 | — |
| Alkermes Investigational Site | Torrance | California | 90502 | — |
| Alkermes Investigational Site | Washington D.C. | District of Columbia | 20016 | — |
| Alkermes Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Alkermes Investigational Site | Leesburg | Florida | 34748 | — |
| Alkermes Investigational Site | Maitland | Florida | 32751 | — |
| Alkermes Investigational Site | Miami | Florida | 33122 | — |
| Alkermes Investigational Site | Miami | Florida | 33136 | — |
| Alkermes Investigational Site | North Miami | Florida | 33021 | — |
| Alkermes Investigational Site | Oakland Park | Florida | 33334 | — |
| Alkermes Investigational Site | Orlando | Florida | 32803 | — |
| Alkermes Investigational Site | Tampa | Florida | 33613 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30308 | — |
| Alkermes Investigational Site | Augusta | Georgia | 30912 | — |
| Alkermes Investigational Site | Decatur | Georgia | 30030 | — |
| Alkermes Investigational Site | Chicago | Illinois | 60640 | — |
| Alkermes Investigational Site | Hoffman Estates | Illinois | 60169 | — |
| Alkermes Investigational Site | Oak Brook | Illinois | 60523 | — |
| Alkermes Investigational Site | Shreveport | Louisiana | 71101 | — |
| Alkermes Investigational Site | Worcester | Massachusetts | 01605 | — |
| Alkermes Investigational Site | Flowood | Mississippi | 39232 | — |
| Alkermes Investigational Site | Creve Coeur | Missouri | 63141 | — |
| Alkermes Investigational Site | Kansas City | Missouri | 64108 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63118 | — |
| Alkermes Investigational Site | Las Vegas | Nevada | 89102 | — |
| Alkermes Investigational Site | Claremont | New Hampshire | 03743 | — |
| Alkermes Investigational Site | Nashua | New Hampshire | 03060 | — |
| Alkermes Investigational Site | Neptune City | New Jersey | 07753 | — |
| Alkermes Investigational Site | Cedarhurst | New York | 11516 | — |
| Alkermes Investigational Site | Jamaica | New York | 11423 | — |
| Alkermes Investigational Site | New York | New York | 10021 | — |
| Alkermes Investigational Site | New York | New York | 10032 | — |
| Alkermes Investigational Site | New York | New York | 10035 | — |
| Alkermes Investigational Site | Rochester | New York | 14642 | — |
| Alkermes Investigational Site | Staten Island | New York | 10312 | — |
| Alkermes Investigational Site | Dayton | Ohio | 45417 | — |
| Alkermes Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Alkermes Investigational Site | Scranton | Pennsylvania | 18503 | — |
| Alkermes Investigational Site | Charleston | South Carolina | 29401 | — |
| Alkermes Investigational Site | Charleston | South Carolina | 29407 | — |
| Alkermes Investigational Site | Charleston | South Carolina | 29425 | — |
| Alkermes Investigational Site | Austin | Texas | 78754 | — |
| Alkermes Investigational Site | Dallas | Texas | 75214 | — |
| Alkermes Investigational Site | DeSoto | Texas | 75115 | — |
| Alkermes Investigational Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02161718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2021 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02161718 live on ClinicalTrials.gov.